Showing results (511-520 of 625) with videos related to
Sort By:
Pageof 63
Scientific Reports|December 4, 2018
Sequence-definition in stiff conjugated oligomersRebekka V Schneider, Kevin A Waibel, Andreas P Arndt, et al.Photomedicine and Laser Surgery|March 18, 2008
Computer-guided CO2-laser osteotomy of the sheep tibia: technical prerequisites and first resultsJohannes J Kuttenberger, Stefan Stübinger, Alessa Waibel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2010
Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?Ansgar Felbecker, William Camu, Paul N Valdmanis, et al.Journal of Diabetes Research|August 29, 2022
Nutritional Interventions May Improve Outcomes of Patients Operated on for Diabetic Foot Infections: A Single-Center Case-Control StudyIlker Uçkay, Vinoth Yogarasa, Felix W A Waibel, et al.Molecular Pharmaceutics|September 26, 2025
Bayesian Optimization for Efficient Multiobjective Formulation Development of BiologicsIsabel Waibel, Timo N Schneider, Fiona J Fischer, et al.Patient Education and Counseling|April 5, 2011
Trust and distrust among Appalachian women regarding cervical cancer screening: a qualitative studyAnn Scheck McAlearney, Jill M Oliveri, Douglas M Post, et al.The Journal of Trauma|August 12, 2009
The elderly trauma patient: an investment for the future?Mark A Newell, Michael F Rotondo, Eric A Toschlog, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|February 13, 2020
Facile preparation of tissue engineering scaffolds with pore size gradients using the muesli effect and their application to cell spheroid encapsulationAurelien Forget, Darling Rojas, Michaela Waibel, et al.Deutsches Arzteblatt International|November 15, 2023
The Outcome of Laparoscopic Versus Open Appendectomy in ChildhoodUdo Rolle, Wolf O Bechstein, Claus Fahlenbrach, et al.The British Journal of Dermatology|January 18, 2022
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trialsGil Yosipovitch, Kim Papp, Seth Forman, et al.Pageof 63